Microbiota-derived deoxycholic and lithocholic acids attenuate diabetic kidney disease through suppression of podocyte ferroptosis via TGR5-SLC7A11 interaction
Abstract
ObjectivesDiabetic kidney disease (DKD) is related to gut dysbiosis, yet the specific causative microbes remain unclear. This study integrated multi-omics, including 16S rRNA sequencing, metagenomics, and bile acid metabolomics on fecal samples from DKD patients and mice.MethodsParabacteroides goldsteinii (P. goldsteinii) was orally administered to DKD mice, with assessment of podocyte injury, glomerular function, renal inflammation, and gut barrier integrity.ResultsIn this study, we found a significant depletion of the gut commensal P. goldsteinii in both murine models and patients with DKD. Oral administration of P. goldsteinii ameliorated podocyte injury, glomerular dysfunction, renal inflammation, and gut barrier disruption in diabetic mice. The protective effects were mediated by microbially derived bile acids, deoxycholic acid (DCA) and lithocholic acid (LCA), which activate Takeda G protein-coupled receptor 5 (TGR5), with the combined treatment producing greater protective effects than either bile acid alone. Furthermore, inhibition of bile acid hydrolysis (BSH) activity blocked the production of DCA/LCA and eliminated the renal benefits of P. goldsteinii. Mechanistically, DCA and LCA inhibited ferroptosis by promoting the interaction between TGR5 and SLC7A11 in podocytes. This interaction may contribute to the preservation of SLC7A11 function and enhancement of cellular antioxidant capacity, thereby attenuating iron-dependent lipid peroxidation. Podocyte-specific knockdown of TGR5 abolished the renoprotection conferred by P. goldsteinii and DCA/LCA.ConclusionCollectively, our work identified a gut–kidney axis in which P. goldsteinii–derived bile acids regulated the TGR5-SLC7A11 macromolecular interaction to suppress podocyte ferroptosis, thereby attenuating DKD progression. These findings revealed a functional interaction between TGR5 and SLC7A11 and highlighted its regulation by microbial metabolites as a potential therapeutic mechanism for DKD.
Related
- Ellagic acid mitigates follicular atresia in laying chickens via GPX4 upregulation to block ferroptosis and p53 suppression to attenuate DNA damage
- Reconsidering the Use of Dimethyl Sulfoxide for Xenobiotic-Gut Microbiota Interaction Studies
- Identification of Antioxidant Plant Extracts and Garcinia amplexicaulis Metabolites with Ferroptosis Inhibitor-like Chemical Properties for Alternative Crop Protection
- A GPX4 phosphorylation switch by FGFR1 guards against ferroptosis
- Oxidized phosphatidylinositol impairs lysosomal membrane repair to promote ferroptosis
BibTeX
@article{zheng2026microbiotaderived,
title = {{Microbiota-derived deoxycholic and lithocholic acids attenuate diabetic kidney disease through suppression of podocyte ferroptosis via TGR5-SLC7A11 interaction}},
author = {Guan-Li Zheng and Ai-Ling Yin and Xi-Xi Lu and Hao-Ting Liu and Ming-Tao Yang and Xue-Xue Zhu and Shi-Bo Lin and Hai-Jian Sun and Qing-Bo Lu},
journal = {Frontiers in Microbiology},
year = {2026},
month = nov,
doi = {10.3389/fmicb.2026.1983926},
url = {https://www.frontiersin.org/articles/10.3389/fmicb.2026.1983926},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Microbiota-derived deoxycholic and lithocholic acids attenuate diabetic kidney disease through suppression of podocyte ferroptosis via TGR5-SLC7A11 interaction
AU - Guan-Li Zheng
AU - Ai-Ling Yin
AU - Xi-Xi Lu
AU - Hao-Ting Liu
AU - Ming-Tao Yang
AU - Xue-Xue Zhu
AU - Shi-Bo Lin
AU - Hai-Jian Sun
AU - Qing-Bo Lu
PY - 2026
DA - 2026/11/03
JO - Frontiers in Microbiology
DO - 10.3389/fmicb.2026.1983926
UR - https://www.frontiersin.org/articles/10.3389/fmicb.2026.1983926
AB - ObjectivesDiabetic kidney disease (DKD) is related to gut dysbiosis, yet the specific causative microbes remain unclear. This study integrated multi-omics, including 16S rRNA sequencing, metagenomics, and bile acid metabolomics on fecal samples from DKD patients and mice.MethodsParabacteroides goldsteinii (P. goldsteinii) was orally administered to DKD mice, with assessment of podocyte injury, glomerular function, renal inflammation, and gut barrier integrity.ResultsIn this study, we found a significant depletion of the gut commensal P. goldsteinii in both murine models and patients with DKD. Oral administration of P. goldsteinii ameliorated podocyte injury, glomerular dysfunction, renal inflammation, and gut barrier disruption in diabetic mice. The protective effects were mediated by microbially derived bile acids, deoxycholic acid (DCA) and lithocholic acid (LCA), which activate Takeda G protein-coupled receptor 5 (TGR5), with the combined treatment producing greater protective effects than either bile acid alone. Furthermore, inhibition of bile acid hydrolysis (BSH) activity blocked the production of DCA/LCA and eliminated the renal benefits of P. goldsteinii. Mechanistically, DCA and LCA inhibited ferroptosis by promoting the interaction between TGR5 and SLC7A11 in podocytes. This interaction may contribute to the preservation of SLC7A11 function and enhancement of cellular antioxidant capacity, thereby attenuating iron-dependent lipid peroxidation. Podocyte-specific knockdown of TGR5 abolished the renoprotection conferred by P. goldsteinii and DCA/LCA.ConclusionCollectively, our work identified a gut–kidney axis in which P. goldsteinii–derived bile acids regulated the TGR5-SLC7A11 macromolecular interaction to suppress podocyte ferroptosis, thereby attenuating DKD progression. These findings revealed a functional interaction between TGR5 and SLC7A11 and highlighted its regulation by microbial metabolites as a potential therapeutic mechanism for DKD.
SN - 1664-302X
ER -